Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression ‌ Archary, D, Rong, R, Gordon, M, Boliar, S, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection. ‌ Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection ‌ Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity ‌ Ackerman, M, Crispin, M, Yu, X, Baruah, K, Boesch, A, Harvey, D, Dugast, A, Heizen, E, Ercan, A, Choi, I, Streeck, H, Nigrovic, P, Bailey-Kellogg, C, Scanlan, C, Alter, G